Atherosclerosis and Lipoprotein Metabolism Flashcards

1
Q

drugs used to treat type IIa Hyperlipoproteinaemia

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

drugs used to treate type I Hyperlipoproteinaemia

A

statins and ezetimibe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

drugs used to treat type IIb Hyperlipoproteinaemia

A

Fibrates, statins, niacin (vitamin B3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

drugs used to treat type III Hyperlipoproteinaemia

A

fibrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

drugs used to treat type IV Hyperlipoproteinaemia

A

fibrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drugs used to treat type V Hyperlipoproteinaemia

A

Fibrates, niacin, fish oil, statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TRUE or FALSE: Loss-of-function single gene defects of LDL receptors give rise to Type IIa hypercholesterolaemia

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Lpa(a) is a type of LDL that contains apo(a), an apolipoprotein structurally like and a competitor of plasminogen. Apo(a) competes with ??? to limit plasmin formation and reduce fibrinolysis and promote thrombosis

A

plasminogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Low intracellular cholesterol increases expression of ??? and LDL receptor (LDL-R) mRNA

A

PCSK9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PCSK9 undergoes autocatalytic processing in the ??? to form mature PCSK9 which is secreted and binds to the LDL-R at the cell surface

A

ER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PCSK9/LDL-R complex binds LDL, which enter the endosomal-lysosomal pathway to mediate degradation and prevent LDL-R recycling to the cell surface = reduction in ???

A

further LDL uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gain OR Loss (?) of-function single PCSK9 gene defects reduce incidence of atherosclerosis

A

gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Angiotensin-converting enzyme inhibitors, Antioxidants (vitamin C, vitamin E) are taken as preventative action to improve ??? function

A

endothelial function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what drugs are taken to improve endothelial function as a preventative for atherosclerosis?

A

Angiotensin-converting enzyme inhibitors, Antioxidants (vitamin C, vitamin E)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Reduce alcohol intake, increase exercise, Anacetrapib (experimental), ApoA-I Milano (experimental) are preventative actions of atherosclerosis to improve ???

A

increase HDLs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is a preventative action taken to reduce C-reactive protein

A

Anti-inflammatories

17
Q

STATINS or FIBRATES inhibit HMG-CoA reductase which is the rate limiting enzyme in cholesterol synthesis

A

statins

18
Q

statins cause decreased ??? synthesis which upregulates LDL receptor synthesis, promoting hepatic LDL uptake and clearance of LDLs from the circulation

A

cholesterol

19
Q

Simvastatin, lovastatin and pravastatin are reversible
inhibitors that fall under the STATIN or FIBRATE drug family?

A

statin

20
Q

Atorvastatin and rosuvastatin are long-lasting inhibitors that are ??? drugs

A

statin

21
Q

PCSK9 inhibitors block PCSK9 from binding to LDL receptors = prevents lysosomal degradation of LDL receptors = more control of ??? concentrations

A

circulating LDL

22
Q

Evolocumab and alirocumab are licensed ??? inhibitors and are examples of monoclonal antibody
therapies

A

PCSK9

23
Q

TRUE or FALSE: Evolocumab and alirocumab are administered
subcutaneously ONLY with statins

A

FALSE: with OR without statins

24
Q

Fibrates activate PPARa to increase transcription of ???, promoting hepatic LDL uptake and clearance of LDLs fromcirculation

A

lipoprotein lipases

25
Q

PPARa forms a heterodimeric nuclear receptor with retinoid X
receptors (RXR) to bind ??? response elements

A

genomic nuclear

26
Q

Fibrates can reduce plasma C-reactive protein and ??? and inhibit vascular smooth muscle inflammation via inhibition of the transcription factor NFkB

A

fibrinogen

27
Q

FIBRATE or STATIN (?) drugs include bezafibrate, ciprofibrate, gemfibrozil, fenofibrate and clofibrate

A

Fibrate

28
Q

which drug groups decrease atherosclerosis?

A

statins, PCSK9 inhibitors, Fibrates